Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does vitamin D need liver hydroxylation before kidney activation?

Vitamin D is first hydroxylated in the liver and then activated in the kidney.

PlausibleAugust 21, 20269 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Vitamin D is hydroxylated in the liver before kidney activation, so hepatobiliary stress signals such as elevated gamma-glutamyl transferase and bilirubin are relevant to vitamin D handling.

laying out figure…
0 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes vitamin D metabolism as a two-step process, with the liver producing circulating 25-hydroxyvitamin D before renal conversion to the active hormone. It also frames elevated gamma-glutamyl transferase and bilirubin as contextual markers that may point to hepatobiliary disease, which can affect vitamin D handling indirectly. The graph emphasizes that these liver tests are not direct measures of vitamin D status on their own.

Verified conclusion

Vitamin D metabolism is sequential: hepatic processing generates the main circulating substrate, followed by predominantly renal hormonal activation. The relevance of liver-test abnormalities is therefore contextual, strongest when they indicate clinically meaningful cholestatic or chronic liver disease.

Mechanistic evidence

  • Vitamin D₃ is first 25-hydroxylated predominantly in the liver, principally by CYP2R1, producing 25-hydroxyvitamin D [25(OH)D; calcidiol], the principal circulating form and standard clinical status marker.
  • 25(OH)D is then converted mainly in renal proximal tubules by mitochondrial CYP27B1 to 1,25-dihydroxyvitamin D [calcitriol], the active hormone. Parathyroid hormone stimulates this step, whereas FGF23 and calcitriol suppress it; CYP24A1 degrades both metabolites.
  • Thus, the liver-to-kidney sequence is well established, although other hepatic 25-hydroxylases and extra-renal CYP27B1 expression contribute in limited contexts.

Hepatobiliary markers and vitamin-D interpretation

  • Elevated GGT or bilirubin can be relevant because they may signal cholestasis or chronic/advanced liver disease. Cholestasis can reduce bile-salt-dependent intestinal absorption of fat-soluble vitamin D and may alter hepatic and vitamin-D-transport protein physiology.
  • Neither marker should be treated as a direct measure of vitamin-D status. Adjusted NHANES data and a study in overweight/obese adults without liver disease found no independent GGT–25(OH)D association; a coronary-disease cohort found an inverse association but has limited generalizability.
  • Hyperbilirubinemia itself does not appear to block hepatic 25-hydroxylation: acute obstructive-jaundice patients generally retained normal 25(OH)D and conversion. In established liver disease, reduced albumin or vitamin-D-binding protein can lower total 25(OH)D without an equivalent fall in bioavailable vitamin D.

Bottom line

  • The metabolic sequence is strongly established; GGT and bilirubin are useful contextual clues to underlying hepatobiliary disease, not standalone evidence of impaired vitamin-D handling or deficiency.

References

  1. Vitamin D Metabolism, Mechanism of Action, and Clinical ... — pmc.ncbi.nlm.nih.gov ↗
  2. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase | PNAS — pnas.org ↗
  3. Metabolism of vitamin D by human microsomal CYP2R1 — sciencedirect.com ↗
  4. Vitamin D metabolism revised: fall of dogmas — pmc.ncbi.nlm.nih.gov ↗
  5. CYP2R1 is a major, but not exclusive, contributor to 25 ... - PNAS — pnas.org ↗
  6. Serum Gamma Glutamyltransferase Is Associated with 25 ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  7. Table 1 — pmc.ncbi.nlm.nih.gov ↗
  8. Vitamin D deficiency in chronic liver disease - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  9. Vitamin D metabolism in acute and chronic cholestasis - PubMed — pubmed.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→